Amicar Related Published Studies
Well-designed clinical trials related to Amicar (Aminocaproic Acid)
Epsilon-aminocaproic acid influence in postoperative [corrected] bleeding and hemotransfusion [corrected] in mitral valve surgery. [2010.10]
A prospective, randomized, double-blinded single-site control study comparing blood loss prevention of tranexamic acid (TXA) to epsilon aminocaproic acid (EACA) for corrective spinal surgery. [2010.04.06]
A prospective, randomized, double-blinded single-site control study comparing
blood loss prevention of tranexamic acid (TXA) to epsilon aminocaproic acid
(EACA) for corrective spinal surgery. [2010]
Effect of epsilon aminocaproic acid on red-cell transfusion requirements in major spinal surgery. [2009.09.01]
The effect of epsilon-aminocaproic acid and aprotinin on fibrinolysis and blood loss in patients undergoing primary, isolated coronary artery bypass surgery: a randomized, double-blind, placebo-controlled, noninferiority trial. [2009.07]
A randomized controlled pilot study of epsilon-aminocaproic acid as a topical hemostatic agent for postoperative bleeding in the sheep model of chronic sinusitis. [2008.03]
Efficacy of aminocaproic, tranexamic acids in the control of bleeding during total knee replacement: a randomized clinical trial. [2006.05]
A double-blind, placebo-controlled trial of epsilon-aminocaproic Acid for reducing blood loss in coronary artery bypass grafting surgery. [2006.02]
The role of amicar in decreasing perioperative blood loss in idiopathic scoliosis. [2005.09.01]
Aprotinin and epsilon aminocaproic acid are effective in reducing blood loss after primary total hip arthroplasty--a prospective randomized double-blind placebo-controlled study. [2005.07]
Comparison of epsilon aminocaproic acid and tranexamic acid in pediatric cardiac surgery. [2004.04]
The effect of amicar on perioperative blood loss in idiopathic scoliosis: the results of a prospective, randomized double-blind study. [2004.02.01]
Effects of epsilon-aminocaproic acid and aprotinin on leukocyte-platelet adhesion in patients undergoing cardiac surgery. [2004.02]
Epsilon-aminocaproic acid in coronary artery bypass graft surgery: preincision or postheparin? [2003.12]
Antifibrinolytic therapy during cardiopulmonary bypass reduces proinflammatory cytokine levels: a randomized, double-blind, placebo-controlled study of epsilon-aminocaproic acid and aprotinin. [2003.11]
A phase III, multicenter, randomized, placebo-controlled clinical trial of topical aminocaproic acid (Caprogel) in the management of traumatic hyphema. [2003.11]
Topical aminocaproic acid to prevent rebleeding in cases of traumatic hyphema. [2003.01]
The effect of epsilon aminocaproic acid on blood loss in patients who undergo primary total hip replacement: a pilot study. [2002.06]
Point-of-care testing for prothrombin time, but not activated partial thromboplastin time, correlates with laboratory methods in patients receiving aprotinin or epsilon-aminocaproic acid while undergoing cardiac surgery. [2002.01]
Aprotinin but not epsilon-aminocaproic acid decreases interleukin-10 after cardiac surgery with extracorporeal circulation: randomized, double-blind, placebo-controlled study in patients receiving aprotinin and epsilon-aminocaproic acid. [2001.09.18]
Postoperatively administered aprotinin or epsilon aminocaproic acid after cardiopulmonary bypass has limited benefit. [2001.08]
Epsilon-aminocaproic acid promotes the release of alpha2-antiplasmin during and after cardiopulmonary bypass. [2001.03]
Comparison of epsilon aminocaproic acid and low-dose aprotinin in cardiopulmonary bypass: efficiency, safety and cost. [2001.03]
Efficacy of aprotinin, epsilon aminocaproic acid, or combination in cyanotic heart disease. [2000.10]
Tranexamic acid reduces red cell transfusion better than epsilon-aminocaproic acid or placebo in liver transplantation. [2000.07]
Postoperative bleeding after coronary revascularization. Comparison between tranexamic acid and epsilon-aminocaproic acid. [2000.06]
Epsilon aminocaproic acid in paediatric cardiac surgery to reduce postoperative blood loss. [2000.02]
Hemostatic effects of aprotinin, tranexamic acid and epsilon-aminocaproic acid in primary cardiac surgery. [1999.12]
The effect of prophylactic epsilon-aminocaproic acid on bleeding, transfusions, platelet function, and fibrinolysis during coronary artery bypass grafting. [1999.08]
A multicenter trial of 6-aminocaproic acid (Amicar) in the prevention of bleeding in infants on ECMO. [1998.11]
The effect of coagulation protection with combination of epsilon aminocaproic acid and plasma saver in open-heart surgery. [1998.09]
High-dose epsilon-aminocaproic acid versus aprotinin: antifibrinolytic efficacy in first-time coronary operations. [1998.03]
Prophylactic tranexamic acid and epsilon-aminocaproic acid for primary myocardial revascularization. [1998.02]
Cost-benefit and efficacy of aprotinin compared with epsilon-aminocaproic acid in patients having repeated cardiac operations: a randomized, blinded clinical trial. [1997.12]
The effects of epsilon-aminocaproic acid on fibrinolysis and thrombin generation during cardiac surgery. [1997.12]
Tranexamic acid reduces bleeding after cardiopulmonary bypass when compared to epsilon aminocaproic acid and placebo. [1997.09]
Topical aminocaproic acid in the treatment of traumatic hyphema. [1997.09]
Reduction of bleeding after heart operations through the prophylactic use of epsilon-aminocaproic acid. [1996.10]
Changes in coagulation patterns, blood loss and blood use after cardiopulmonary bypass: aprotinin vs tranexamic acid vs epsilon aminocaproic acid. [1996.08]
The effect of low-dose epsilon-aminocaproic acid on patients following coronary artery bypass surgery. [1996.01]
Clinical evaluation of aminocaproic acid for managing traumatic hyphema in children. [1995.11]
Effect of prophylactic epsilon-aminocaproic acid on blood loss and transfusion requirements in patients undergoing first-time coronary artery bypass grafting. A randomized, prospective, double-blind study. [1994.07]
Decreased postoperative drainage with addition of epsilon-aminocaproic acid before cardiopulmonary bypass. [1994.05]
[Comparison of the effects of epsilon-aminocaproic acid and aprotinin on intra- and postoperative bleeding in heart surgery] [1992]
Well-designed clinical trials possibly related to Amicar (Aminocaproic Acid)
Medical interventions for traumatic hyphema. [2011.01.19]
Blood conservation strategies for reducing peri-operative blood loss in open heart surgery. [2011.01]
Topical use of antifibrinolytic agent to reduce postoperative bleeding after coronary artery bypass surgery. [2009.09]
A comparison of aprotinin and lysine analogues in high-risk cardiac surgery. [2008.05.29]
The effect of intravesical instillation of antifibrinolytic agents on bacillus Calmette-Guerin treatment of superficial bladder cancer: a pilot study. [2008.04]
Effects of topical antifibrinolytics in endoscopic sinus surgery: a pilot randomized controlled trial. [2007.11]
Aprotinin use in cardiac surgery patients at low risk for requiring blood transfusion. [2007.07]
Meta-analysis comparing the effectiveness and adverse outcomes of antifibrinolytic agents in cardiac surgery. [2007.06.05]
Evaluation of Epsilon amino-caproic acid (EACA) and autologous blood as blood conservation strategies in patients undergoing cardiac surgery. [2006.08]
[Clinical investigation on the effect of intravesical instillation of antifibrinolytic agents with bacillus Calmette-Guerin on preventing bladder cancer recurrence] [2005.11.15]
Collagen degradation by host-derived enzymes during aging. [2004.03]
Antifibrinolytic therapy and perioperative blood loss in cancer patients undergoing major orthopedic surgery. [2003.02]
The efficacy of antifibrinolytics in the reduction of blood loss during complex adult reconstructive spine surgery. [2001.05.15]
[Endoscopic, histologic and morphometric evaluation of the gastric mucosa in patients with osteoarthritis treated with piroxicam and zinc acexamate] [1998.05]
Continuous small-dose tranexamic acid reduces fibrinolysis but not transfusion requirements during orthotopic liver transplantation. [1997.08]
Intraoperative antifibrinolysis and blood-saving techniques in cardiac surgery. Prospective trial of 3 antifibrinolytic drugs. [1995]
Multicenter clinical trial of zinc acexamate in the prevention of nonsteroidal antiinflammatory drug induced gastroenteropathy. Spanish Study Group on NSAID Induced Gastroenteropathy Prevention. [1994.05]
The effect of warm heart surgery on postoperative bleeding. [1992.06]
[Comparative study of 3 drugs (aceglutamide aluminum, zinc acexamate, and magaldrate) in the long-term maintenance treatment (1 year) of peptic ulcer] [1991.08]
Other research related to Amicar (Aminocaproic Acid)
Seizures after open heart surgery: comparison of epsilon-aminocaproic acid and tranexamic acid. [2011.02]
epsilon-Aminocaproic acid and clinical value in cardiac anesthesia. [2011.02]
Effects of intravenous aminocaproic acid on exercise-induced pulmonary haemorrhage (EIPH). [2010.11]
epsilon-Aminocaproic Acid and Clinical Value in Cardiac Anesthesia. [2010.09.24]
Preliminary experience with epsilon aminocaproic acid for treatment of intractable upper tract hematuria in children with hematological disorders. [2010.09]
The effective concentration of epsilon-aminocaproic Acid for inhibition of fibrinolysis in neonatal plasma in vitro. [2010.07]
Interstitial plasmin activity with epsilon aminocaproic acid: temporal and regional heterogeneity. [2010.05]
Low dose, oral epsilon aminocaproic acid for renal papillary necrosis and massive hemorrhage in hemoglobin SC disease. [2010.01]
Synergistic inhibition of influenza A virus replication by a plant polyphenol-rich extract and epsilon-aminocaproic acid in vitro and in vivo. [2010]
The effect of aprotinin, tranexamic acid, and aminocaproic acid on blood loss and use of blood products in major pediatric surgery: a meta-analysis. [2009.03]
The effect of aprotinin, tranexamic acid, and aminocaproic acid on blood loss and use of blood products in major pediatric surgery: A meta-analysis. [2009.01.30]
Acute promyelocytic leukaemia and acquired alpha-2-plasmin inhibitor deficiency: a retrospective look at the use of epsilon-aminocaproic acid (Amicar) in 30 patients. [2008.12]
Role of Amicar in surgery for neuromuscular scoliosis. [2008.11.15]
Role of Amicar in surgery for neuromuscular scoliosis. [2008.11.15]
The role of Amicar in same-day anterior and posterior spinal fusion for idiopathic scoliosis. [2008.09.15]
The role of Amicar in same-day anterior and posterior spinal fusion for idiopathic scoliosis. [2008.09.15]
Acute promyelocytic leukaemia and acquired alpha-2-plasmin inhibitor deficiency: a retrospective look at the use of epsilon-aminocaproic acid (Amicar) in 30 patients. [2008.07.09]
Differential effects of epsilon-aminocaproic acid and aprotinin on matrix metalloproteinase release in patients following cardiopulmonary bypass. [2008.04]
Perioperative renal outcome in cardiac surgical patients with preoperative renal dysfunction: aprotinin versus epsilon aminocaproic acid. [2008.02]
Efficacy of serum therapy on the treatment of rats experimentally envenomed by bristle extract of the caterpillar Lonomia obliqua: comparison with epsilon-aminocaproic acid therapy. [2007.09.01]
Use of low molecular weight heparin and aminocaproic acid in chronic DIC associated with prostate cancer--a case report. [2007.02.02]
Fibrinogen levels following Amicar in surgery for idiopathic scoliosis. [2007.02.01]
Fibrinogen levels following Amicar in surgery for idiopathic scoliosis. [2007.02.01]
Epsilon-aminocaproic acid inhibition of fibrinolysis in vitro: should the 'therapeutic' concentration be reconsidered? [2007.01]
Aminocaproic-acid seal to reduce or prevent bleeding after liver biopsy. [2007.01]
Diffuse alveolar hemorrhage: retrospective review of clinical outcome in allogeneic transplant recipients treated with aminocaproic acid. [2006.09]
Epsilon aminocaproic acid reduces transfusion requirements in patients with thrombocytopenic hemorrhage. [2006.07.01]
Successful use of recombinant activated FVII and aminocaproic acid in four neonates with life-threatening hemorrhage. [2006.07]
The efficacy and safety of epsilon-aminocaproic acid treatment in patients with cirrhosis and hyperfibrinolysis. [2006.01.01]
Other possibly related research studies
Cell-penetrating peptides as transporters for morpholino oligomers: effects of amino acid composition on intracellular delivery and cytotoxicity. [2007]
Management of patients refractory to platelet transfusion. [2007.07]
[Practical management of C1 inhibitor deficiency] [2007.05]
[Hereditary angioedema in a 16-year-old girl] [2006]
Video-assisted thoracoscopic surgery in idiopathic scoliosis: evaluation of the learning curve. [2007.03.15]
Metabolic profile of a peptide-conjugated chlorin-type photosensitizer targeting neuropilin-1: an in vivo and in vitro study. [2007.05]
Efficacy and safety of antifibrinolytic drugs in liver transplantation: a systematic review and meta-analysis. [2007.01]
Hereditary angioedema: the clinical syndrome and its management in the United States. [2006.11]
Do Antifibrinolytics Reduce Allogeneic Blood Transfusion in Orthopedic Surgery? [2006.11]
|
